Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH: Deciphera Pharmaceuticals Inc is a biotechnology company, which develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition, it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations function through the region of the United States.
moreShow DCPH Financials
Recent trades of DCPH by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by DCPH's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Methods of treating disorders using csf1r inhibitors Jun. 20, 2023
-
Patent Title: Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea Mar. 28, 2023
-
Patent Title: Aminopyrimidine amide autophagy inhibitors and methods of use thereof Feb. 28, 2023
-
Patent Title: Methods of treating gastrointestinal stromal tumors Feb. 14, 2023
-
Patent Title: Amorphous kinase inhibitor formulations and methods of use thereof Feb. 14, 2023
-
Patent Title: Methods of treating gastrointestinal stromal tumors Dec. 27, 2022
-
Patent Title: Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof Dec. 20, 2022
-
Patent Title: Methods of treating gastrointestinal stromal tumors Dec. 20, 2022
-
Patent Title: Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof Dec. 06, 2022
-
Patent Title: Methods of treating gastrointestinal stromal tumors Sep. 06, 2022
-
Patent Title: Methods of treating gastrointestinal stromal tumors Aug. 30, 2022
-
Patent Title: Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea Jul. 26, 2022
-
Patent Title: Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof Jul. 19, 2022
-
Patent Title: Methods of treating gastrointestinal stromal tumors May. 31, 2022
-
Patent Title: Methods of treating gastrointestinal stromal tumors Mar. 08, 2022
-
Patent Title: Amorphous kinase inhibitor formulations and methods of use thereof Nov. 30, 2021
-
Patent Title: Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases Sep. 14, 2021
-
Patent Title: Methods of treating disorders using csf1r inhibitors Aug. 31, 2021
-
Patent Title: Methods of treating gastrointestinal stromal tumors Apr. 06, 2021
-
Patent Title: Methods for inhibiting tie-2 kinase useful in the treatment of cancer Oct. 04, 2016
-
Patent Title: Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities Jul. 12, 2016
-
Patent Title: N-acyl-n′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities Jul. 05, 2016
-
Patent Title: Raf inhibitor compounds May. 10, 2016
-
Patent Title: N-acyl-n′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities Apr. 12, 2016
-
Patent Title: 1,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activities Nov. 24, 2015
-
Patent Title: Raf inhibitor compounds Nov. 17, 2015
-
Patent Title: 2-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activities Nov. 10, 2015
-
Patent Title: Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activities Sep. 15, 2015
-
Patent Title: Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities Apr. 21, 2015
-
Patent Title: Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases Jan. 27, 2015
-
Patent Title: Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities Dec. 30, 2014
-
Patent Title: Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities Jan. 28, 2014
-
Patent Title: Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases Nov. 19, 2013
-
Patent Title: Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities Oct. 29, 2013
-
Patent Title: Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities Jul. 16, 2013
-
Patent Title: Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases Jun. 11, 2013
-
Patent Title: N-acyl ureas exhibiting anti-cancer and anti-proliferative activities Oct. 02, 2012
-
Patent Title: Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases May. 29, 2012
-
Patent Title: Enzyme modulators and treatments Apr. 24, 2012
-
Patent Title: Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases Mar. 27, 2012
-
Patent Title: Kinase inhibitors useful for the treatment of proliferative diseases Mar. 01, 2011
-
Patent Title: Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases Sep. 07, 2010
-
Patent Title: Anti-inflammatory medicaments Jun. 15, 2010
-
Patent Title: Anti-inflammatory medicaments Feb. 23, 2010
Federal grants, loans, and purchases
Followers on DCPH's company Twitter account
Number of mentions of DCPH in WallStreetBets Daily Discussion
Recent insights relating to DCPH
Recent picks made for DCPH stock on CNBC
ETFs with the largest estimated holdings in DCPH
Flights by private jets registered to DCPH